Heico Corp. (0J46)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 308.17 |
|---|---|
| 52-week range | 256.71 – 385.08 |
| Return, 1 month / 3 months | +3.9% / −10.8% |
| Return, 1 year / 3 years | +0.3% / +88.7% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 33.2% |
| Worst drawdown (1 year) | -27.6% |
| Average daily value traded | 0.04M USD |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Heico Corp. makes aerospace and defence hardware, including replacement parts for jet engines and aircraft, along with electronic and electro-optical components. Its flight support business supplies airlines, repair stations and maintenance providers with aftermarket parts, while its electronic technologies business serves aerospace, defence and industrial customers with specialised devices. The company is based in Florida in the United States and sells to customers around the world.
Heico Corp. trades under the code 0J46 on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Heico Corp. (0J46) trades on the London Exchange in UK. It last closed at USD 308.17 on 19 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 2,569 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.3% and over the last three months it fell 10.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.2% | ||
| From 52-week high | -17.4% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.8% | ||
| 6-month return | 5.3% | ||
| 12-month return, skipping the last month | -3.5% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.6% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.04M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 20 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.3% |
|---|---|
| 1 month | +3.9% |
| 3 months | −10.8% |
| 6 months | +5.3% |
| 1 year | +0.3% |
| 3 years | +88.7% |
| 5 years | +121.2% |
Signals
| 50-day / 200-day average | 324.49 / 321.54 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 10.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jan 2026 | USD 0.1200 |
| 1 Jul 2025 | USD 0.1200 |
| 3 Jan 2025 | USD 0.1100 |
| 1 Jul 2024 | USD 0.1100 |
| 3 Jan 2024 | USD 0.1000 |
| 30 Jun 2023 | USD 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.